Abstract
Sphingosine 1-phosphate (S1P) is an important lipid biomolecule that exerts pleiotropic cellular actions as it binds to and activates its five G-protein-coupled receptors, S1P1–5. Through these receptors, S1P can mediate diverse biological activities in both healthy and diseased conditions. S1P is produced by S1P-producing enzymes, sphingosine kinases (SphK1 and SphK2), and is abundantly present in different organs, including the brain. The medically important roles of receptor-mediated S1P signaling are well characterized in multiple sclerosis because FTY720 (Gilenya™, Novartis), a non-selective S1P receptor modulator, is currently used as a treatment for this disease. In cerebral ischemia, its role is also notable because of FTY720’s efficacy in both rodent models and human patients with cerebral ischemia. In particular, some of the S1P receptors, including S1P1, S1P2, and S1P3, have been identified as pathogenic players in cerebral ischemia. Other than these receptors, S1P itself and S1P-producing enzymes have been shown to play certain roles in cerebral ischemia. This review aims to compile the current updates and overviews about the roles of S1P signaling, along with a focus on S1P receptors in cerebral ischemia, based on recent studies that used in vivo rodent models of cerebral ischemia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
All data used for this review are available within a manuscript.
References
Allende, M. L., Bektas, M., Lee, B. G., Bonifacino, E., Kang, J., Tuymetova, G., et al. (2011). Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking. Journal of Biological Chemistry, 286(9), 7348–7358. https://doi.org/10.1074/jbc.M110.171819.
Awad, A. S., Ye, H., Huang, L., Li, L., Foss, F. W., Jr., Macdonald, T. L., et al. (2006). Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia–reperfusion injury in mouse kidney. American Journal of Physiology-Renal Physiology, 290(6), F1516–F1524. https://doi.org/10.1152/ajprenal.00311.2005.
Bajwa, A., Huang, L., Kurmaeva, E., Gigliotti, J. C., Ye, H., Miller, J., et al. (2016). Sphingosine 1-phosphate receptor 3-deficient dendritic cells modulate splenic responses to ischemia–reperfusion injury. Journal of American Society of Nephrology, 27(4), 1076–1090. https://doi.org/10.1681/ASN.2015010095.
Bajwa, A., Huang, L., Ye, H., Dondeti, K., Song, S., Rosin, D. L., et al. (2012). Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia–reperfusion injury. Journal of Immunology, 189(5), 2584–2596. https://doi.org/10.4049/jimmunol.1200999.
Block, M. L., Zecca, L., & Hong, J. S. (2007). Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nature Reviews Neuroscience, 8(1), 57–69. https://doi.org/10.1038/nrn2038.
Blondeau, N., Lai, Y., Tyndall, S., Popolo, M., Topalkara, K., Pru, J. K., et al. (2007). Distribution of sphingosine kinase activity and mRNA in rodent brain. Journal of Neurochemistry, 103(2), 509–517. https://doi.org/10.1111/j.1471-4159.2007.04755.x.
Bobinger, T., Manaenko, A., Burkardt, P., Beuscher, V., Sprugel, M. I., Roeder, S. S., et al. (2019). Siponimod (BAF-312) attenuates perihemorrhagic edema and improves survival in experimental intracerebral hemorrhage. Stroke, 50(11), 3246–3254. https://doi.org/10.1161/STROKEAHA.119.027134.
Brait, V. H., Tarrason, G., Gavalda, A., Godessart, N., & Planas, A. M. (2016). Selective sphingosine 1-phosphate receptor 1 agonist is protective against ischemia/reperfusion in mice. Stroke, 47(12), 3053–3056. https://doi.org/10.1161/STROKEAHA.116.015371.
Choi, J. W., & Chun, J. (2013). Lysophospholipids and their receptors in the central nervous system. Biochimica Biophysica Acta, 1831(1), 20–32. https://doi.org/10.1016/j.bbalip.2012.07.015.
Choi, J. W., Gardell, S. E., Herr, D. R., Rivera, R., Lee, C. W., Noguchi, K., et al. (2011). FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proceedings of the National Academy of Sciences of USA, 108(2), 751–756. https://doi.org/10.1073/pnas.1014154108.
Chun, J., & Brinkmann, V. (2011). A mechanistically novel, first oral therapy for multiple sclerosis: The development of fingolimod (FTY720, Gilenya). Discovery Medicine, 12(64), 213–228.
Chun, J., & Hartung, H. P. (2010). Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clinical Neuropharmacology, 33(2), 91–101. https://doi.org/10.1097/WNF.0b013e3181cbf825.
Colombo, E., & Farina, C. (2016). Astrocytes: Key regulators of neuroinflammation. Trends in Immunology, 37(9), 608–620. https://doi.org/10.1016/j.it.2016.06.006.
Cuzzocrea, S., Doyle, T., Campolo, M., Paterniti, I., Esposito, E., Farr, S. A., et al. (2018). Sphingosine 1-phosphate receptor subtype 1 as a therapeutic target for brain trauma. Journal of Neurotrauma, 35(13), 1452–1466. https://doi.org/10.1089/neu.2017.5391.
Czech, B., Pfeilschifter, W., Mazaheri-Omrani, N., Strobel, M. A., Kahles, T., Neumann-Haefelin, T., et al. (2009). The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. Biochemical and Biophysical Research Communication, 389(2), 251–256. https://doi.org/10.1016/j.bbrc.2009.08.142.
Dusaban, S. S., Chun, J., Rosen, H., Purcell, N. H., & Brown, J. H. (2017). Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes. Journal of Neuroinflammation, 14(1), 111. https://doi.org/10.1186/s12974-017-0882-x.
Fagan, S. C., Morgenstern, L. B., Petitta, A., Ward, R. E., Tilley, B. C., Marler, J. R., et al. (1998). Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology, 50(4), 883–890. https://doi.org/10.1212/wnl.50.4.883.
Fischer, I., Alliod, C., Martinier, N., Newcombe, J., Brana, C., & Pouly, S. (2011). Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions. PLoS ONE, 6(8), e23905. https://doi.org/10.1371/journal.pone.0023905.
Font, M. A., Arboix, A., & Krupinski, J. (2010). Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke. Current Cardiology Reviews, 6(3), 238–244. https://doi.org/10.2174/157340310791658802.
Foster, C. A., Mechtcheriakova, D., Storch, M. K., Balatoni, B., Howard, L. M., Bornancin, F., et al. (2009). FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: Expression of central nervous system genes and reversal of blood–brain-barrier damage. Brain Pathology, 19(2), 254–266. https://doi.org/10.1111/j.1750-3639.2008.00182.x.
Fu, Y., Hao, J., Zhang, N., Ren, L., Sun, N., Li, Y. J., et al. (2014a). Fingolimod for the treatment of intracerebral hemorrhage: A 2-arm proof-of-concept study. JAMA Neurology, 71(9), 1092–1101. https://doi.org/10.1001/jamaneurol.2014.1065.
Fu, Y., Zhang, N., Ren, L., Yan, Y., Sun, N., Li, Y. J., et al. (2014b). Impact of an immune modulator fingolimod on acute ischemic stroke. Proceedings of the National Academy of Sciences of USA, 111(51), 18315–18320. https://doi.org/10.1073/pnas.1416166111.
Gaire, B. P., Bae, Y. J., & Choi, J. W. (2019). S1P1 regulates M1/M2 polarization toward brain injury after transient focal cerebral ischemia. Biomolecules and Therapeutics (Seoul),, https://doi.org/10.4062/biomolther.2019.005.
Gaire, B. P., Lee, C. H., Sapkota, A., Lee, S. Y., Chun, J., Cho, H. J., et al. (2018a). Identification of sphingosine 1-phosphate receptor subtype 1 (S1P1) as a pathogenic factor in transient focal cerebral ischemia. Molecular Neurobiology, 55(3), 2320–2332. https://doi.org/10.1007/s12035-017-0468-8.
Gaire, B. P., Song, M. R., & Choi, J. W. (2018b). Sphingosine 1-phosphate receptor subtype 3 (S1P3) contributes to brain injury after transient focal cerebral ischemia via modulating microglial activation and their M1 polarization. Journal of Neuroinflammation, 15(1), 284. https://doi.org/10.1186/s12974-018-1323-1.
Gentile, A., Musella, A., Bullitta, S., Fresegna, D., De Vito, F., Fantozzi, R., et al. (2016). Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis. Journal of Neuroinflammation, 13(1), 207. https://doi.org/10.1186/s12974-016-0686-4.
Graler, M. H., & Goetzl, E. J. (2004). The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB Journal, 18(3), 551–553. https://doi.org/10.1096/fj.03-0910fje.
Covenant Community Health and Wellness Group. (2016). Meta-analysis of rare and common exome chip variants identifies S1PR4 and other loci influencing blood cell traits. Nature Genetics, 48(8), 867–876. https://doi.org/10.1038/ng.3607.
Gulke, E., Gelderblom, M., & Magnus, T. (2018). Danger signals in stroke and their role on microglia activation after ischemia. Therapeutic Advances in Neurological Disorders, 11, 1756286418774254. https://doi.org/10.1177/1756286418774254.
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Davalos, A., Guidetti, D., et al. (2008). Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. New England Journal of Medicine, 359(13), 1317–1329, https://doi.org/10.1056/NEJMoa0804656.
Hamanaka, G., Ohtomo, R., Takase, H., Lok, J., & Arai, K. (2018). White-matter repair: Interaction between oligodendrocytes and the neurovascular unit. Brain Circulation, 4(3), 118–123. https://doi.org/10.4103/bc.bc_15_18.
Hasegawa, Y., Suzuki, H., Altay, O., Rolland, W., & Zhang, J. H. (2013). Role of the sphingosine metabolism pathway on neurons against experimental cerebral ischemia in rats. Translational Stroke Research, 4(5), 524–532. https://doi.org/10.1007/s12975-013-0260-7.
Hasegawa, Y., Suzuki, H., Sozen, T., Rolland, W., & Zhang, J. H. (2010). Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke, 41(2), 368–374. https://doi.org/10.1161/STROKEAHA.109.568899.
Herr, D. R., Grillet, N., Schwander, M., Rivera, R., Muller, U., & Chun, J. (2007). Sphingosine 1-phosphate (S1P) signaling is required for maintenance of hair cells mainly via activation of S1P2. Journal of Neuroscience, 27(6), 1474–1478. https://doi.org/10.1523/JNEUROSCI.4245-06.2007.
Jaillard, C., Harrison, S., Stankoff, B., Aigrot, M. S., Calver, A. R., Duddy, G., et al. (2005). Edg8/S1P5: An oligodendroglial receptor with dual function on process retraction and cell survival. Journal of Neuroscience, 25(6), 1459–1469. https://doi.org/10.1523/JNEUROSCI.4645-04.2005.
Jayaraj, R. L., Azimullah, S., Beiram, R., Jalal, F. Y., & Rosenberg, G. A. (2019). Neuroinflammation: Friend and foe for ischemic stroke. Journal of Neuroinflammation, 16(1), 142. https://doi.org/10.1186/s12974-019-1516-2.
Jickling, G. C., Liu, D., Ander, B. P., Stamova, B., Zhan, X., & Sharp, F. R. (2015). Targeting neutrophils in ischemic stroke: Translational insights from experimental studies. Journal of Cerebral Blood Flow and Metabolism, 35(6), 888–901. https://doi.org/10.1038/jcbfm.2015.45.
Jones, K. A., Maltby, S., Plank, M. W., Kluge, M., Nilsson, M., Foster, P. S., et al. (2018). Peripheral immune cells infiltrate into sites of secondary neurodegeneration after ischemic stroke. Brain, Behavior and Immunity, 67, 299–307. https://doi.org/10.1016/j.bbi.2017.09.006.
Kaminska, B., Gozdz, A., Zawadzka, M., Ellert-Miklaszewska, A., & Lipko, M. (2009). MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anatomical Record (Hoboken), 292(12), 1902–1913. https://doi.org/10.1002/ar.21047.
Karunakaran, I., & van Echten-Deckert, G. (2017). Sphingosine 1-phosphate—A double edged sword in the brain. Biochimica et Biophysica Acta Biomembranes, 1859(9 Pt B), 1573–1582, https://doi.org/10.1016/j.bbamem.2017.03.008.
Kawabori, M., & Yenari, M. A. (2015). The role of the microglia in acute CNS injury. Metabolic Brain Disease, 30(2), 381–392. https://doi.org/10.1007/s11011-014-9531-6.
Kim, G. S., Yang, L., Zhang, G., Zhao, H., Selim, M., McCullough, L. D., et al. (2015). Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke. Nature Communications, 6, 7893. https://doi.org/10.1038/ncomms8893.
Kimura, A., Ohmori, T., Kashiwakura, Y., Ohkawa, R., Madoiwa, S., Mimuro, J., et al. (2008). Antagonism of sphingosine 1-phosphate receptor-2 enhances migration of neural progenitor cells toward an area of brain. Stroke, 39(12), 3411–3417. https://doi.org/10.1161/STROKEAHA.108.514612.
Kimura, A., Ohmori, T., Ohkawa, R., Madoiwa, S., Mimuro, J., Murakami, T., et al. (2007). Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury. Stem Cells, 25(1), 115–124. https://doi.org/10.1634/stemcells.2006-0223.
Kraft, P., Gob, E., Schuhmann, M. K., Gobel, K., Deppermann, C., Thielmann, I., et al. (2013). FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection. Stroke, 44(11), 3202–3210. https://doi.org/10.1161/STROKEAHA.113.002880.
Kunz, A., Abe, T., Hochrainer, K., Shimamura, M., Anrather, J., Racchumi, G., et al. (2008). Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion. Journal of Neuroscience, 28(7), 1649–1658. https://doi.org/10.1523/JNEUROSCI.5205-07.2008.
Kwiatkowski, T. G., Libman, R. B., Frankel, M., Tilley, B. C., Morgenstern, L. B., Lu, M., et al. (1999). Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. New England Journal of Medicine, 340(23), 1781–1787, https://doi.org/10.1056/NEJM199906103402302.
Lepley, D., Paik, J. H., Hla, T., & Ferrer, F. (2005). The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration. Cancer Research, 65(9), 3788–3795. https://doi.org/10.1158/0008-5472.CAN-04-2311.
Li, K., Li, J., Zheng, J., & Qin, S. (2019). Reactive astrocytes in neurodegenerative diseases. Aging Diseases, 10(3), 664–675. https://doi.org/10.14336/AD.2018.0720.
Lien, Y. H., Yong, K. C., Cho, C., Igarashi, S., & Lai, L. W. (2006). S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Internatiional, 69(9), 1601–1608. https://doi.org/10.1038/sj.ki.5000360.
Lin, C. I., Chen, C. N., Lin, P. W., & Lee, H. (2007). Sphingosine 1-phosphate regulates inflammation-related genes in human endothelial cells through S1P1 and S1P3. Biochemical and Biophysical Research Communications, 355(4), 895–901. https://doi.org/10.1016/j.bbrc.2007.02.043.
Lin, J. J., Chang, T., Cai, W. K., Zhang, Z., Yang, Y. X., Sun, C., et al. (2015). Post-injury administration of allicin attenuates ischemic brain injury through sphingosine kinase 2: In vivo and in vitro studies. Neurochemistry International, 89, 92–100. https://doi.org/10.1016/j.neuint.2015.07.022.
Lv, M., Zhang, D., Dai, D., Zhang, W., & Zhang, L. (2016). Sphingosine kinase 1/sphingosine-1-phosphate regulates the expression of interleukin-17A in activated microglia in cerebral ischemia/reperfusion. Inflammation Research, 65(7), 551–562. https://doi.org/10.1007/s00011-016-0939-9.
MacLennan, A. J., Benner, S. J., Andringa, A., Chaves, A. H., Rosing, J. L., Vesey, R., et al. (2006). The S1P2 sphingosine 1-phosphate receptor is essential for auditory and vestibular function. Hearing Research, 220(1–2), 38–48. https://doi.org/10.1016/j.heares.2006.06.016.
MacLennan, A. J., Carney, P. R., Zhu, W. J., Chaves, A. H., Garcia, J., Grimes, J. R., et al. (2001). An essential role for the H218/AGR16/Edg-5/LP(B2) sphingosine 1-phosphate receptor in neuronal excitability. European Journal of Neuroscience, 14(2), 203–209. https://doi.org/10.1046/j.0953-816x.2001.01634.x.
Matsumoto, N., Yamashita, T., Shang, J., Feng, T., Osakada, Y., Sasaki, R., et al. (2020). Up-regulation of sphingosine-1-phosphate receptors and sphingosine kinase 1 in the peri-ischemic area after transient middle cerebral artery occlusion in mice. Brain Research,, https://doi.org/10.1016/j.brainres.2020.146831.
Moon, E., Han, J. E., Jeon, S., Ryu, J. H., Choi, J. W., & Chun, J. (2015). Exogenous S1P exposure potentiates ischemic stroke damage that is reduced possibly by inhibiting S1P receptor signaling. Mediators of Inflammation, 2015, 492659. https://doi.org/10.1155/2015/492659.
Mullershausen, F., Craveiro, L. M., Shin, Y., Cortes-Cros, M., Bassilana, F., Osinde, M., et al. (2007). Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors. Journal of Neurochemistry, 102(4), 1151–1161. https://doi.org/10.1111/j.1471-4159.2007.04629.x.
Nayak, D., Huo, Y., Kwang, W. X., Pushparaj, P. N., Kumar, S. D., Ling, E. A., et al. (2010). Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. Neuroscience, 166(1), 132–144. https://doi.org/10.1016/j.neuroscience.2009.12.020.
Nazari, M., Keshavarz, S., Rafati, A., Namavar, M. R., & Haghani, M. (2016). Fingolimod (FTY720) improves hippocampal synaptic plasticity and memory deficit in rats following focal cerebral ischemia. Brain Research Bulletin, 124, 95–102. https://doi.org/10.1016/j.brainresbull.2016.04.004.
Novgorodov, A. S., El-Alwani, M., Bielawski, J., Obeid, L. M., & Gudz, T. I. (2007). Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. FASEB Journal, 21(7), 1503–1514. https://doi.org/10.1096/fj.06-7420com.
Nussbaum, C., Bannenberg, S., Keul, P., Graler, M. H., Goncalves-de-Albuquerque, C. F., Korhonen, H., et al. (2015). Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin. Nature Communications, 6, 6416. https://doi.org/10.1038/ncomms7416.
O’Sullivan, C., & Dev, K. K. (2013). The structure and function of the S1P1 receptor. Trends in Pharmacological Science, 34(7), 401–412. https://doi.org/10.1016/j.tips.2013.05.002.
O'Sullivan, C., Schubart, A., Mir, A. K., & Dev, K. K. (2016). The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures. Journal of Neuroinflammation, 13, 31. https://doi.org/10.1186/s12974-016-0494-x.
Obinata, H., & Hla, T. (2012). Sphingosine 1-phosphate in coagulation and inflammation. Seminars in Immunopathology, 34(1), 73–91. https://doi.org/10.1007/s00281-011-0287-3.
Okajima, F., Tomura, H., Sho, K., Nochi, H., Tamoto, K., & Kondo, Y. (1996). Involvement of pertussis toxin-sensitive GTP-binding proteins in sphingosine 1-phosphate-induced activation of phospholipase C-Ca2+ system in HL60 leukemia cells. FEBS Letters, 379(3), 260–264. https://doi.org/10.1016/0014-5793(95)01526-4.
Olesch, C., Ringel, C., Brune, B., & Weigert, A. (2017). Beyond immune cell migration: The emerging role of the sphingosine-1-phosphate receptor S1PR4 as a modulator of innate immune cell activation. Mediators of Inflammation, 2017, 6059203. https://doi.org/10.1155/2017/6059203.
Oo, M. L., Thangada, S., Wu, M. T., Liu, C. H., Macdonald, T. L., Lynch, K. R., et al. (2007). Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. Journal of Biological Chemistry, 282(12), 9082–9089. https://doi.org/10.1074/jbc.M610318200.
Osinde, M., Mullershausen, F., & Dev, K. K. (2007). Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. Neuropharmacology, 52(5), 1210–1218. https://doi.org/10.1016/j.neuropharm.2006.11.010.
Paugh, B. S., Bryan, L., Paugh, S. W., Wilczynska, K. M., Alvarez, S. M., Singh, S. K., et al. (2009). Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells. Journal of Biological Chemistry, 284(6), 3408–3417. https://doi.org/10.1074/jbc.M807170200.
Pfeilschifter, W., Czech-Zechmeister, B., Sujak, M., Mirceska, A., Koch, A., Rami, A., et al. (2011). Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia. Biochemical and Biophysical Research Communications, 413(2), 212–217. https://doi.org/10.1016/j.bbrc.2011.08.070.
Porter, H., Qi, H., Prabhu, N., Grambergs, R., McRae, J., Hopiavuori, B., et al. (2018). Characterizing sphingosine kinases and sphingosine 1-phosphate receptors in the mammalian eye and retina. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms19123885.
Postma, F. R., Jalink, K., Hengeveld, T., & Moolenaar, W. H. (1996). Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: Action through a specific cell surface receptor. EMBO Journal, 15(10), 2388–2392.
Qureshi, A. I., Mendelow, A. D., & Hanley, D. F. (2009). Intracerebral haemorrhage. Lancet, 373(9675), 1632–1644. https://doi.org/10.1016/S0140-6736(09)60371-8.
Rosen, H., Gonzalez-Cabrera, P. J., Sanna, M. G., & Brown, S. (2009). Sphingosine 1-phosphate receptor signaling. Annual Review of Biochemistry, 78, 743–768. https://doi.org/10.1146/annurev.biochem.78.072407.103733.
Ruan, L., Wang, B., ZhuGe, Q., & Jin, K. (2015). Coupling of neurogenesis and angiogenesis after ischemic stroke. Brain Research, 1623, 166–173. https://doi.org/10.1016/j.brainres.2015.02.042.
Sadahira, Y., Ruan, F., Hakomori, S., & Igarashi, Y. (1992). Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness. Proceedings of the National Academy of Sciences of USA, 89(20), 9686–9690. https://doi.org/10.1073/pnas.89.20.9686.
Salas-Perdomo, A., Miro-Mur, F., Gallizioli, M., Brait, V. H., Justicia, C., Meissner, A., et al. (2019). Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke. Scientific Reports, 9(1), 8309. https://doi.org/10.1038/s41598-019-44845-5.
Sanada, Y., Mizushima, T., Kai, Y., Nishimura, J., Hagiya, H., Kurata, H., et al. (2011). Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis. PLoS ONE, 6(9), e23933. https://doi.org/10.1371/journal.pone.0023933.
Sanchez, T., & Hla, T. (2004). Structural and functional characteristics of S1P receptors. Journal of Cellular Biochemistry, 92(5), 913–922. https://doi.org/10.1002/jcb.20127.
Sapkota, A., Gaire, B. P., Kang, M. G., & Choi, J. W. (2019). S1P2 contributes to microglial activation and M1 polarization following cerebral ischemia through ERK1/2 and JNK. Scientific Reports, 9(1), 12106. https://doi.org/10.1038/s41598-019-48609-z.
Sato, K., Ui, M., & Okajima, F. (2000). Differential roles of Edg-1 and Edg-5, sphingosine 1-phosphate receptors, in the signaling pathways in C6 glioma cells. Brain Research Molecular Brain Research, 85(1–2), 151–160. https://doi.org/10.1016/s0169-328x(00)00262-x.
Sawano, T., Watanabe, F., Ishiguchi, M., Doe, N., Furuyama, T., & Inagaki, S. (2015). Effect of Sema4D on microglial function in middle cerebral artery occlusion mice. Glia, 63(12), 2249–2259. https://doi.org/10.1002/glia.22890.
Scott, F. L., Clemons, B., Brooks, J., Brahmachary, E., Powell, R., Dedman, H., et al. (2016). Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1) and receptor-5 (S1P5) agonist with autoimmune disease-modifying activity. British Journal of Pharmacology, 173(11), 1778–1792. https://doi.org/10.1111/bph.13476.
Shang, K., He, J., Zou, J., Qin, C., Lin, L., Zhou, L. Q., et al. (2020). Fingolimod promotes angiogenesis and attenuates ischemic brain damage via modulating microglial polarization. Brain Research, 1726, 146509. https://doi.org/10.1016/j.brainres.2019.146509.
Shichita, T., Sugiyama, Y., Ooboshi, H., Sugimori, H., Nakagawa, R., Takada, I., et al. (2009). Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nature Medicine, 15(8), 946–950. https://doi.org/10.1038/nm.1999.
Song, D. D., Zhang, T. T., Chen, J. L., Xia, Y. F., Qin, Z. H., Waeber, C., et al. (2017). Sphingosine kinase 2 activates autophagy and protects neurons against ischemic injury through interaction with Bcl-2 via its putative BH3 domain. Cell Death and Disease, 8(7), e2912. https://doi.org/10.1038/cddis.2017.289.
Sorensen, S. D., Nicole, O., Peavy, R. D., Montoya, L. M., Lee, C. J., Murphy, T. J., et al. (2003). Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Molecular Pharmacology, 64(5), 1199–1209. https://doi.org/10.1124/mol.64.5.1199.
Stroemer, R. P., Kent, T. A., & Hulsebosch, C. E. (1995). Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats. Stroke, 26(11), 2135–2144. https://doi.org/10.1161/01.str.26.11.2135.
Sturmer, T., Schlindwein, G., Kleiser, B., Roempp, A., & Brenner, H. (2002). Clinical diagnosis of ischemic versus hemorrhagic stroke: Applicability of existing scores in the emergency situation and proposal of a new score. Neuroepidemiology, 21(1), 8–17. https://doi.org/10.1159/000048608.
Su, D., Cheng, Y., Li, S., Dai, D., Zhang, W., & Lv, M. (2017). Sphk1 mediates neuroinflammation and neuronal injury via TRAF2/NF-kappaB pathways in activated microglia in cerebral ischemia reperfusion. Journal of Neuroimmunology, 305, 35–41. https://doi.org/10.1016/j.jneuroim.2017.01.015.
Subei, A. M., & Cohen, J. A. (2015). Sphingosine 1-phosphate receptor modulators in multiple sclerosis. CNS Drugs, 29(7), 565–575. https://doi.org/10.1007/s40263-015-0261-z.
Sun, N., Shen, Y., Han, W., Shi, K., Wood, K., Fu, Y., et al. (2016). Selective sphingosine-1-phosphate receptor 1 modulation attenuates experimental intracerebral hemorrhage. Stroke, 47(7), 1899–1906. https://doi.org/10.1161/STROKEAHA.115.012236.
Sun, W., Ding, Z., Xu, S., Su, Z., & Li, H. (2017). Crosstalk between TLR2 and Sphk1 in microglia in the cerebral ischemia/reperfusion-induced inflammatory response. International Journal of Molecular Medicine, 40(6), 1750–1758. https://doi.org/10.3892/ijmm.2017.3165.
Takano, T., Oberheim, N., Cotrina, M. L., & Nedergaard, M. (2009). Astrocytes and ischemic injury. Stroke, 40(3 Suppl), S8–12. https://doi.org/10.1161/STROKEAHA.108.533166.
Taylor, R. A., & Sansing, L. H. (2013). Microglial responses after ischemic stroke and intracerebral hemorrhage. Clinical and Developmental Immunology, 2013, 746068. https://doi.org/10.1155/2013/746068.
Tiper, I. V., East, J. E., Subrahmanyam, P. B., & Webb, T. J. (2016). Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection. Pathogens and Disease. https://doi.org/10.1093/femspd/ftw063.
Toman, R. E., Payne, S. G., Watterson, K. R., Maceyka, M., Lee, N. H., Milstien, S., et al. (2004). Differential transactivation of sphingosine-1-phosphate receptors modulates NGF-induced neurite extension. Journal of Cell Biology, 166(3), 381–392. https://doi.org/10.1083/jcb.200402016.
van Doorn, R., Lopes Pinheiro, M. A., Kooij, G., Lakeman, K., van het Hof, B., van der Pol, S. M., et al. (2012). Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier. Journal of Neuroinflammation, 9, 133. https://doi.org/10.1186/1742-2094-9-133.
van Koppen, C., Meyer zu Heringdorf, M., Laser, K. T., Zhang, C., Jakobs, K. H., Bunemann, M., et al. (1996). Activation of a high affinity Gi protein-coupled plasma membrane receptor by sphingosine-1-phosphate. Journal of Biological Chemistry, 271(4), 2082–2087. https://doi.org/10.1074/jbc.271.4.2082.
Vogelgesang, A., Domanska, G., Ruhnau, J., Dressel, A., Kirsch, M., & Schulze, J. (2019). Siponimod (BAF312) treatment reduces brain infiltration but not lesion volume in middle-aged mice in experimental stroke. Stroke, 50(5), 1224–1231. https://doi.org/10.1161/STROKEAHA.118.023667.
Volpi, C., Orabona, C., Macchiarulo, A., Bianchi, R., Puccetti, P., & Grohmann, U. (2019). Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis. Expert Opinion on Drug Discovery, 14(11), 1199–1212. https://doi.org/10.1080/17460441.2019.1646244.
Wacker, B. K., Freie, A. B., Perfater, J. L., & Gidday, J. M. (2012a). Junctional protein regulation by sphingosine kinase 2 contributes to blood–brain barrier protection in hypoxic preconditioning-induced cerebral ischemic tolerance. Journal of Cerebral Blood Flow and Metabolism, 32(6), 1014–1023. https://doi.org/10.1038/jcbfm.2012.3.
Wacker, B. K., Park, T. S., & Gidday, J. M. (2009). Hypoxic preconditioning-induced cerebral ischemic tolerance: Role of microvascular sphingosine kinase 2. Stroke, 40(10), 3342–3348. https://doi.org/10.1161/STROKEAHA.109.560714.
Wacker, B. K., Perfater, J. L., & Gidday, J. M. (2012b). Hypoxic preconditioning induces stroke tolerance in mice via a cascading HIF, sphingosine kinase, and CCL2 signaling pathway. Journal of Neurochemistry, 123(6), 954–962. https://doi.org/10.1111/jnc.12047.
Wan, Y., Jin, H. J., Zhu, Y. Y., Fang, Z., Mao, L., He, Q., et al. (2018). MicroRNA-149-5p regulates blood–brain barrier permeability after transient middle cerebral artery occlusion in rats by targeting S1PR2 of pericytes. FASEB Journal, 32(6), 3133–3148. https://doi.org/10.1096/fj.201701121R.
Wei, Y., Yemisci, M., Kim, H. H., Yung, L. M., Shin, H. K., Hwang, S. K., et al. (2011). Fingolimod provides long-term protection in rodent models of cerebral ischemia. Annals of Neurology, 69(1), 119–129. https://doi.org/10.1002/ana.22186.
White, B. C., Sullivan, J. M., DeGracia, D. J., O'Neil, B. J., Neumar, R. W., Grossman, L. I., et al. (2000). Brain ischemia and reperfusion: Molecular mechanisms of neuronal injury. Journal of Neurological Sciences, 179(S 1–2), 1–33, https://doi.org/10.1016/s0022-510x(00)00386-5.
Yenari, M. A., Kauppinen, T. M., & Swanson, R. A. (2010). Microglial activation in stroke: Therapeutic targets. Neurotherapeutics, 7(4), 378–391. https://doi.org/10.1016/j.nurt.2010.07.005.
Yester, J. W., Bryan, L., Waters, M. R., Mierzenski, B., Biswas, D. D., Gupta, A. S., et al. (2015). Sphingosine-1-phosphate inhibits IL-1-induced expression of C-C motif ligand 5 via c-Fos-dependent suppression of IFN-beta amplification loop. FASEB Journal, 29(12), 4853–4865. https://doi.org/10.1096/fj.15-275180.
Young, N., & Van Brocklyn, J. R. (2007). Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness. Experimental Cell Research, 313(8), 1615–1627, https://doi.org/10.1016/j.yexcr.2007.02.009.
Yung, L. M., Wei, Y., Qin, T., Wang, Y., Smith, C. D., & Waeber, C. (2012). Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury. Stroke, 43(1), 199–204. https://doi.org/10.1161/STROKEAHA.111.626911.
Zhang, H., Desai, N. N., Olivera, A., Seki, T., Brooker, G., & Spiegel, S. (1991). Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. Journal of Cell Biology, 114(1), 155–167. https://doi.org/10.1083/jcb.114.1.155.
Zhang, S. (2019). Microglial activation after ischaemic stroke. Stroke and Vascular Neurology, 4(2), 71–74. https://doi.org/10.1136/svn-2018-000196.
Zhao, J., Garcia, D., Gartung, A., & Lee, M. J. (2015). Sphingosine-1-phosphate receptor subtype 2 signaling in endothelial senescence-associated functional impairments and inflammation. Current Atherosclerosis Reports, 17(5), 504. https://doi.org/10.1007/s11883-015-0504-y.
Zheng, S., Wei, S., Wang, X., Xu, Y., Xiao, Y., Liu, H., et al. (2015). Sphingosine kinase 1 mediates neuroinflammation following cerebral ischemia. Experimental Neurology, 272, 160–169. https://doi.org/10.1016/j.expneurol.2015.03.012.
Zhu, Z., Fu, Y., Tian, D., Sun, N., Han, W., Chang, G., et al. (2015). Combination of the immune modulator fingolimod with alteplase in acute ischemic stroke: A pilot trial. Circulation, 132(12), 1104–1112. https://doi.org/10.1161/CIRCULATIONAHA.115.016371.
Funding
This research was supported by the National Research Foundation (NRF) of Korea (NRF-2020R1A6A1A03043708) and the Gachon University Research Fund of 2019 (GCU-2019-0308) to JWC.
Author information
Authors and Affiliations
Contributions
BPG and JWC performed literature search, data analysis, and wrote the manuscript. JWC presented the idea of this review article.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gaire, B.P., Choi, J.W. Sphingosine 1-Phosphate Receptors in Cerebral Ischemia. Neuromol Med 23, 211–223 (2021). https://doi.org/10.1007/s12017-020-08614-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-020-08614-2